あすか製薬ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/04/07 | 2,068 | 2,140 | 2,068 | 2,093 | -125 | -5.6% | 94,500 |
2025/04/04 | 2,234 | 2,262 | 2,187 | 2,218 | -66 | -2.9% | 73,800 |
2025/04/03 | 2,203 | 2,293 | 2,203 | 2,284 | -16 | -0.7% | 57,200 |
2025/04/02 | 2,310 | 2,315 | 2,272 | 2,300 | -20 | -0.9% | 46,600 |
2025/04/01 | 2,313 | 2,341 | 2,312 | 2,320 | +16 | +0.7% | 34,000 |
2025/03/31 | 2,300 | 2,317 | 2,290 | 2,304 | -6 | -0.3% | 46,200 |
2025/03/28 | 2,301 | 2,322 | 2,290 | 2,310 | -32 | -1.4% | 52,900 |
2025/03/27 | 2,324 | 2,344 | 2,314 | 2,342 | +18 | +0.8% | 40,700 |
2025/03/26 | 2,307 | 2,329 | 2,283 | 2,324 | -6 | -0.3% | 57,100 |
2025/03/25 | 2,300 | 2,331 | 2,300 | 2,330 | +30 | +1.3% | 16,400 |
2025/03/24 | 2,307 | 2,317 | 2,292 | 2,300 | -7 | -0.3% | 26,800 |
2025/03/21 | 2,300 | 2,311 | 2,292 | 2,307 | +7 | +0.3% | 30,300 |
2025/03/19 | 2,277 | 2,323 | 2,256 | 2,300 | +6 | +0.3% | 67,900 |
2025/03/18 | 2,317 | 2,325 | 2,294 | 2,294 | -41 | -1.8% | 37,000 |
2025/03/17 | 2,302 | 2,338 | 2,287 | 2,335 | +10 | +0.4% | 46,200 |
2025/03/14 | 2,324 | 2,334 | 2,303 | 2,325 | +8 | +0.3% | 46,100 |
2025/03/13 | 2,300 | 2,320 | 2,298 | 2,317 | +31 | +1.4% | 52,500 |
2025/03/12 | 2,299 | 2,309 | 2,265 | 2,286 | +21 | +0.9% | 58,200 |
2025/03/11 | 2,201 | 2,268 | 2,201 | 2,265 | +51 | +2.3% | 67,100 |
2025/03/10 | 2,200 | 2,238 | 2,200 | 2,214 | +14 | +0.6% | 36,800 |
2025/03/07 | 2,160 | 2,209 | 2,160 | 2,200 | +30 | +1.4% | 75,200 |
2025/03/06 | 2,165 | 2,180 | 2,162 | 2,170 | +24 | +1.1% | 38,200 |
2025/03/05 | 2,150 | 2,185 | 2,125 | 2,146 | +47 | +2.2% | 59,400 |
2025/03/04 | 2,082 | 2,112 | 2,080 | 2,099 | +24 | +1.2% | 49,500 |
2025/03/03 | 2,080 | 2,100 | 2,059 | 2,075 | +45 | +2.2% | 51,300 |
2025/02/28 | 1,999 | 2,034 | 1,997 | 2,030 | +42 | +2.1% | 79,400 |
2025/02/27 | 1,969 | 1,994 | 1,962 | 1,988 | +19 | +1% | 36,700 |
2025/02/26 | 1,944 | 1,969 | 1,939 | 1,969 | +25 | +1.3% | 45,400 |
2025/02/25 | 1,919 | 1,944 | 1,900 | 1,944 | +18 | +0.9% | 44,100 |
2025/02/21 | 1,967 | 1,967 | 1,920 | 1,926 | -22 | -1.1% | 41,900 |
2025/02/20 | 1,953 | 1,966 | 1,935 | 1,948 | -15 | -0.8% | 37,900 |
2025/02/19 | 1,962 | 1,969 | 1,946 | 1,963 | +13 | +0.7% | 34,700 |
2025/02/18 | 1,938 | 1,959 | 1,929 | 1,950 | +12 | +0.6% | 32,300 |
2025/02/17 | 1,943 | 1,964 | 1,934 | 1,938 | -36 | -1.8% | 22,200 |
2025/02/14 | 1,965 | 1,981 | 1,964 | 1,974 | +4 | +0.2% | 32,800 |
2025/02/13 | 1,940 | 1,970 | 1,938 | 1,970 | +48 | +2.5% | 31,300 |
2025/02/12 | 1,940 | 1,940 | 1,917 | 1,922 | ±0 | ±0% | 35,500 |
2025/02/10 | 1,922 | 1,947 | 1,922 | 1,922 | ±0 | ±0% | 26,500 |
2025/02/07 | 1,933 | 1,940 | 1,917 | 1,922 | +22 | +1.2% | 32,500 |
2025/02/06 | 1,895 | 1,910 | 1,876 | 1,900 | +15 | +0.8% | 38,000 |
2025/02/05 | 1,885 | 1,885 | 1,852 | 1,885 | +29 | +1.6% | 49,400 |
2025/02/04 | 1,849 | 1,907 | 1,825 | 1,856 | -33 | -1.7% | 137,100 |
2025/02/03 | 1,930 | 1,931 | 1,842 | 1,889 | -78 | -4% | 149,200 |
2025/01/31 | 1,986 | 1,986 | 1,954 | 1,967 | +8 | +0.4% | 37,200 |
2025/01/30 | 1,970 | 1,978 | 1,953 | 1,959 | -4 | -0.2% | 37,800 |
2025/01/29 | 1,978 | 1,982 | 1,963 | 1,963 | -23 | -1.2% | 45,900 |
2025/01/28 | 1,972 | 1,989 | 1,970 | 1,986 | +14 | +0.7% | 42,100 |
2025/01/27 | 1,967 | 1,974 | 1,953 | 1,972 | +32 | +1.6% | 70,400 |
2025/01/24 | 1,948 | 1,967 | 1,930 | 1,940 | -2 | -0.1% | 79,600 |
2025/01/23 | 1,952 | 1,952 | 1,933 | 1,942 | -20 | -1% | 88,500 |
1~
50
件表示中 / 982件
類似銘柄と比較する
現在ご覧いただいている「あすかHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
あすかHD | 209,300円 | +0.3% | +2.7% | 2.39% | 11.87倍 | 0.92倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
ジーエヌアイ | 149,000円 | +21.7% | +999.9% | 0.00% | 6.20倍 | 2.05倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ネクセラファーマ | 69,600円 | +22.8% | - | 0.00% | 56.86倍 | 0.91倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
クオリプス | 664,000円 | +660.9% | - | 0.00% | - | 9.63倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
JCRファーマ | 39,300円 | -23.0% | - | 5.09% | - | 0.85倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム